Bio-Techne Corporation
TECH
$55.89
-$1.96-3.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.22B | 1.22B | 1.21B | 1.20B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.22B | 1.22B | 1.22B | 1.21B | 1.20B |
| Cost of Revenue | 405.94M | 403.53M | 408.52M | 403.75M | 400.67M |
| Gross Profit | 809.63M | 813.20M | 811.12M | 805.02M | 795.35M |
| SG&A Expenses | 445.45M | 454.76M | 450.98M | 493.35M | 451.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 949.37M | 958.15M | 958.99M | 985.31M | 945.12M |
| Operating Income | 266.21M | 258.58M | 260.64M | 223.46M | 250.90M |
| Income Before Tax | 114.19M | 106.28M | 98.46M | 162.98M | 185.79M |
| Income Tax Expenses | 33.09M | 28.30M | 25.06M | 31.32M | 27.66M |
| Earnings from Continuing Operations | 81.10 | 77.99 | 73.40 | 131.67 | 158.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.10M | 77.99M | 73.40M | 131.67M | 158.14M |
| EBIT | 266.21M | 258.58M | 260.64M | 223.46M | 250.90M |
| EBITDA | 369.94M | 364.68M | 370.54M | 334.31M | 361.49M |
| EPS Basic | 0.52 | 0.50 | 0.46 | 0.83 | 1.00 |
| Normalized Basic EPS | 1.06 | 1.02 | 1.03 | 0.85 | 0.94 |
| EPS Diluted | 0.50 | 0.48 | 0.45 | 0.83 | 1.00 |
| Normalized Diluted EPS | 1.05 | 1.02 | 1.02 | 0.84 | 0.92 |
| Average Basic Shares Outstanding | 623.59M | 626.18M | 629.25M | 632.20M | 632.14M |
| Average Diluted Shares Outstanding | 628.06M | 631.69M | 636.44M | 641.34M | 642.89M |
| Dividend Per Share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Payout Ratio | 61.50% | 64.30% | 68.65% | 38.45% | 32.02% |